Introduction Pulmonary embolism (PE) is a common and significant source of mortality and
morbidity worldwide. A subset of patients with PE, particularly those who have intermediate …

Long-term right ventricular (RV) function, functional capacity, exercise capacity, and quality
of life following pulmonary embolism (PE), and the impact of thrombolysis, are unclear. A …

2 Vascular Medicine 00 (0) adjudication process with access to the medical record allowed
for a more rigorous assessment. Mortality in patients with intermediate-risk PE is estimated …

Patients with intermediate-risk pulmonary embolism (PE), or those with evidence of right
ventricular (RV) dysfunction by imaging or biomarker data without hypotension, represent a …

As we step into 2024, the field of pulmonary embolism (PE) research stands at a unique
juncture. Traditional interest concerning venous thromboembolism risk factors and medical …

Guidelines for management of normotensive patients with acute pulmonary embolism (PE)
emphasize further risk stratification on the basis of right ventricular (RV) size and biomarkers …

Pulmonary embolism (PE) is the third most common cause of cardiovascular death and
necessitates prompt, accurate risk assessment at initial diagnosis to guide treatment and …

Background Right ventricular (RV) function plays a critical role in the pathophysiology and
acute prognosis of pulmonary embolism (PE). We analyzed the temporal changes of RV …

Pulmonary embolism (PE) is a common medical condition that carries significant morbidity
and mortality. Although diagnosis, anticoagulation, and interventional clot-burden reduction …

Background The mortality associated with high-risk pulmonary embolism (PE) is remarkably
high, and reperfusion to unload right ventricle should be a priority. However, several …